Vivos Therapeuticsinc Stock Technical Analysis
| VVOS Stock | USD 2.65 0.01 0.38% |
As of the 24th of April, Vivos TherapeuticsInc has the Risk Adjusted Performance of (0.09), variance of 50.43, and Coefficient Of Variation of (610.22). In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Vivos TherapeuticsInc, as well as the relationship between them. In other words, you can use this information to find out if the company will indeed mirror its model of past prices and volume data, or the prices will eventually revert. We were able to break down and interpolate data for thirteen technical drivers for Vivos TherapeuticsInc, which can be compared to its competition. Please validate Vivos TherapeuticsInc risk adjusted performance, information ratio, as well as the relationship between the Information Ratio and kurtosis to decide if Vivos TherapeuticsInc is priced more or less accurately, providing market reflects its prevalent price of 2.65 per share. Please also confirm Vivos TherapeuticsInc jensen alpha, which is currently at (1.26) to double-check the company can sustain itself at a future point.
Vivos TherapeuticsInc Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Vivos, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to VivosVivos |
Vivos TherapeuticsInc Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 1.8 | Strong Buy | 2 | Odds |
Most Vivos analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Vivos stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Vivos TherapeuticsInc, talking to its executives and customers, or listening to Vivos conference calls.
Vivos TherapeuticsInc technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Vivos TherapeuticsInc Technical Analysis
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Vivos TherapeuticsInc volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Vivos TherapeuticsInc Trend Analysis
Use this graph to draw trend lines for Vivos TherapeuticsInc. You can use it to identify possible trend reversals for Vivos TherapeuticsInc as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Vivos TherapeuticsInc price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Vivos TherapeuticsInc Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Vivos TherapeuticsInc applied against its price change over selected period. The best fit line has a slop of 0.06 , which may suggest that Vivos TherapeuticsInc market price will keep on failing further. It has 122 observation points and a regression sum of squares at 144.71, which is the sum of squared deviations for the predicted Vivos TherapeuticsInc price change compared to its average price change.About Vivos TherapeuticsInc Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Vivos TherapeuticsInc on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Vivos TherapeuticsInc based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Vivos TherapeuticsInc price pattern first instead of the macroeconomic environment surrounding Vivos TherapeuticsInc. By analyzing Vivos TherapeuticsInc's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Vivos TherapeuticsInc's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Vivos TherapeuticsInc specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2021 | 2023 | 2024 (projected) | Payables Turnover | 4.65 | 2.87 | 2.37 | Days Of Inventory On Hand | 5.9E-5 | 6.8E-5 | 6.5E-5 |
Vivos TherapeuticsInc April 24, 2024 Technical Indicators
Most technical analysis of Vivos help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Vivos from various momentum indicators to cycle indicators. When you analyze Vivos charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.09) | |||
| Market Risk Adjusted Performance | (1.06) | |||
| Mean Deviation | 4.8 | |||
| Coefficient Of Variation | (610.22) | |||
| Standard Deviation | 7.1 | |||
| Variance | 50.43 | |||
| Information Ratio | (0.18) | |||
| Jensen Alpha | (1.26) | |||
| Total Risk Alpha | (2.09) | |||
| Treynor Ratio | (1.07) | |||
| Maximum Drawdown | 52.45 | |||
| Value At Risk | (10.79) | |||
| Potential Upside | 7.85 | |||
| Skewness | (0.47) | |||
| Kurtosis | 4.96 |
Vivos TherapeuticsInc April 24, 2024 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Vivos stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 1,171 | ||
| Daily Balance Of Power | 0.11 | ||
| Rate Of Daily Change | 1.00 | ||
| Day Median Price | 2.66 | ||
| Day Typical Price | 2.65 | ||
| Price Action Indicator | 0.00 |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vivos TherapeuticsInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons. For more information on how to buy Vivos Stock please use our How to Invest in Vivos TherapeuticsInc guide.You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Complementary Tools for Vivos Stock analysis
When running Vivos TherapeuticsInc's price analysis, check to measure Vivos TherapeuticsInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vivos TherapeuticsInc is operating at the current time. Most of Vivos TherapeuticsInc's value examination focuses on studying past and present price action to predict the probability of Vivos TherapeuticsInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vivos TherapeuticsInc's price. Additionally, you may evaluate how the addition of Vivos TherapeuticsInc to your portfolios can decrease your overall portfolio volatility.
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |
Is Vivos TherapeuticsInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vivos TherapeuticsInc. If investors know Vivos will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vivos TherapeuticsInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (11.14) | Revenue Per Share 11.318 | Quarterly Revenue Growth (0.18) | Return On Assets (0.88) | Return On Equity (5.21) |
The market value of Vivos TherapeuticsInc is measured differently than its book value, which is the value of Vivos that is recorded on the company's balance sheet. Investors also form their own opinion of Vivos TherapeuticsInc's value that differs from its market value or its book value, called intrinsic value, which is Vivos TherapeuticsInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vivos TherapeuticsInc's market value can be influenced by many factors that don't directly affect Vivos TherapeuticsInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vivos TherapeuticsInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Vivos TherapeuticsInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vivos TherapeuticsInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.